126 related articles for article (PubMed ID: 18820244)
1. Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma?
Dizdar O; Aksoy S; Altundag K
Ann Oncol; 2009 Jan; 20(1):189; author reply 189-90. PubMed ID: 18820244
[No Abstract] [Full Text] [Related]
2. Is there any role for new prognostic markers in breast cancer?
Barnadas A
Clin Transl Oncol; 2012 Mar; 14(3):161-2. PubMed ID: 22374417
[No Abstract] [Full Text] [Related]
3. Chairperson's introduction: Despite significant advances in the diagnosis and treatment of breast cancer, approximately one third of patients still develop, and subsequently die from metastatic breast disease.
Johnston SR
Eur J Cancer; 2011 Sep; 47 Suppl 3():S4-5. PubMed ID: 21944027
[No Abstract] [Full Text] [Related]
4. Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?
Lopez-Bonet E; Menendez JA
Ann Oncol; 2010 Apr; 21(4):901-902. PubMed ID: 20032125
[No Abstract] [Full Text] [Related]
5. Survival from breast cancer in England and Wales up to 2001.
Leary A; Smith IE
Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S56-8. PubMed ID: 18813261
[No Abstract] [Full Text] [Related]
6. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic value of Id protein family in human breast carcinoma.
Yang HY; Liu HL; Ke J; Wu H; Zhu H; Liu JR; Liu LX; Jiang HC
Oncol Rep; 2010 Feb; 23(2):321-8. PubMed ID: 20043091
[TBL] [Abstract][Full Text] [Related]
8. Low expression of Mel-18 predicts poor prognosis in patients with breast cancer.
Guo BH; Zhang X; Zhang HZ; Lin HL; Feng Y; Shao JY; Huang WL; Kung HF; Zeng MS
Ann Oncol; 2010 Dec; 21(12):2361-2369. PubMed ID: 20444850
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
[TBL] [Abstract][Full Text] [Related]
10. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E
Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319
[TBL] [Abstract][Full Text] [Related]
11. [Better prognosis and favorable tumor stages in patients with invasive breast mammary carcinoma after introduction of the mass screening of breast cancer in Tilburg, the Netherlands].
Groenendijk RP; Bult P; Wobbes T
Ned Tijdschr Geneeskd; 2004 May; 148(19):961; author reply 961-2. PubMed ID: 15160564
[No Abstract] [Full Text] [Related]
12. Intrinsic Subgroups or Individual Biomarkers for Predicting Outcome of Metastatic Breast Cancer?
Dowsett M
JAMA Oncol; 2016 Oct; 2(10):1269-1271. PubMed ID: 27281312
[No Abstract] [Full Text] [Related]
13. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
Sheikh UN; Cohen C; Siddiqui MT
Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
[TBL] [Abstract][Full Text] [Related]
14. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
15. Nm23H1 and p53 proteins are differentially correlated to metastasis in breast carcinoma.
Srinivas P; Madhavan M; Ahamed I; Abraham E; Vijayalakshmy NR; Balaram P
Neoplasma; 2002; 49(4):225-30. PubMed ID: 12382019
[TBL] [Abstract][Full Text] [Related]
16. [Medullary breast cancer].
Frank GA; Volchenko NN
Sov Med; 1986; (8):37-40. PubMed ID: 3022398
[No Abstract] [Full Text] [Related]
17. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
18. Predicting the survival of patients with breast carcinoma using tumor size.
Michaelson JS; Silverstein M; Wyatt J; Weber G; Moore R; Halpern E; Kopans DB; Hughes K
Cancer; 2002 Aug; 95(4):713-23. PubMed ID: 12209713
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing survival in infiltrating lobular carcinoma of the breast.
Sariego J; Byrd M; Kerstein M; Matsumoto T
Am Surg; 1993 Jul; 59(7):405-9. PubMed ID: 8391768
[TBL] [Abstract][Full Text] [Related]
20. Impact of breast cancer subtypes and patterns of metastasis on outcome.
Kast K; Link T; Friedrich K; Petzold A; Niedostatek A; Schoffer O; Werner C; Klug SJ; Werner A; Gatzweiler A; Richter B; Baretton G; Wimberger P
Breast Cancer Res Treat; 2015 Apr; 150(3):621-9. PubMed ID: 25783184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
